Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 268-596-7 | CAS number: 68130-53-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 31 March 2014 to 05 May 2014
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study performed in accordance with OECD test guidelines in compliance with GLP.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 014
- Report date:
- 2014
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Test material form:
- other: liquid
- Details on test material:
- Reference Name: H2925 (CAS No. 68130-53-0)Label Identification: HATCOL 2925, Lot No. 2013090401, 14 Mar 14Quantity & Date Received: 20 Mar 14; 679.5 g (GW)Physical Description: Colorless to light amber liquidStorage: Room temperaturePurity: Not provided to testing facilityStability: Not provided to testing facilityConcentrations Administered: 100%; 50 and 25% in 4:1 acetone:olive oilData generated for characterization and stability is the responsibility of the Sponsor.
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- Species & Strain: Mouse; CBA/Jcr
Justification of Species: The mouse is species of choice for a local lymph node assay to provide information on which human hazard can be judged.
Source: Harlan Sprague-Dawley; Indianapolis, IN
Quantity & Sex: 5 females per each Test group & 5 females in each Control group (all nulliparous & non-pregnant)
Quarantine Period: 5 days
Date Born/Date Received: 21 Feb 14 / 17 Apr 14
Anima/Group Identification: Tail marking / Cage card
Weights on Initial Dose Day: 20.4-26.3 g
Cage Type: Polycarbonate boxes with bedding
Housing: 1 - 5 per cage
Environmental Controls: Set to Maintain: Temperature: 22° ± 3°C; Relative humidity: 30 - 70%; 12-hour light/dark cycle; 10+ air changes per hour
Temperature/Rel. Humidity: 19-23°C/52-84%
Food: PMI Feeds Inc.™ Formulab #5008; available ad libitum
Water: Municipal water supply analyzed by TCEQ Water Utilities Division; available ad libitum from automatic water system
Animal husbandry and housing at STILLMEADOW, Inc. comply with standards outlined in "Guide for the Care and Use of Laboratory Animals" (NRC Publ.). No contaminants were expected to have been present in feed or water that would have interfered with or affected results of the study.
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- Each Test animal in its group received an open application of 25 µL of appropriate dilution (25 or 50%) of test substance, or 100% test substance undiluted.
- No. of animals per dose:
- 5 mice per dose group
- Details on study design:
- Test Substance Preparation and Administration: Healthy mice were released from quarantine prior to testing. Five females were selected for each of three Test groups (Groups I- III). On Days 1, 2 and 3, each Test animal in its group received an open application of 25 µL of appropriate dilution (25 or 50%) of test substance, or 100% test substance undiluted, to the dorsum of both ears. The Vehicle Control group (5 females) was treated the same way as test animals, but with vehicle alone instead of test substance. The Positive Control group (5 females) was treated with alpha-hexylcinnamaldehyde as received. All Test and Control animals were given a two-day rest period on Days 4 and 5.
Injection of Tritiated Methvl-Thymidine: On Day 6 of the study, all Test and Control animals were injected in the tail vein with 250 µL of 0.01 M phosphate-buffered saline (PBS; Sigma, Lot 081M8207, Exp Nov 2021), pH 7.4 at 25°C per manufacturer, containing 20 µCi of [methyl-3H) Thymidine (PerkinElmer, Lot 201404, Exp Apr 2015). Five hours after injection, animals were sacrificed with an overdose of CO2, the draining auricular lymph nodes excised and pairs from each individual animal processed.
Suspension Preparation and DPM Determination: A single cell suspension was prepared by gentle mechanical disintegration through 200 mesh stainless steel gauze. Cells were washed twice with an excess of PBS and precipitated with 5% trichloroacetic acid (TCA; Ricca Chemical, Lot 2403 813, Exp Mar 20 15) at 4°C for 18 hours. The pellets were resuspended in 1 mL of TCA and transferred to 10 mL of scintillation fluid. Incorporation of tritiated thymidine was measured by liquid scintillation counting as disintegrations per minute (DPM) from paired lymph nodes of each animal, and mean DPM/animal was calculated for each group.
Body Weights and Observations: Individual body weights were recorded on Day 1 prior to dosing, and Day 6, prior to injection. All Test and Control animals were observed daily for clinical signs of toxicity and any signs of excessive irritation at the test site. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- Not specified in the study report.
Results and discussion
- Positive control results:
- Reported in table form - detailed under Any other information
In vivo (LLNA)
Resultsopen allclose all
- Key result
- Parameter:
- SI
- Value:
- 1.7
- Test group / Remarks:
- Test Group I
- Key result
- Parameter:
- SI
- Value:
- 1.4
- Test group / Remarks:
- Test Group II
- Key result
- Parameter:
- SI
- Value:
- 1.3
- Test group / Remarks:
- Test Group III
Any other information on results incl. tables
Stimulation Index or Test/Vehicle Control Ration derived for each Test group based on group mean DPM is as follows.
Animal Group |
Test Substance Concentration |
Average Count per Mouse |
Number if Mice in Group |
Test/Vehicle Control Ratio |
Vehicle Control |
NA |
699 |
5 |
NA |
Test Group I |
25% |
1173 |
5 |
1.7 |
Test Group II |
50% |
993 |
5 |
1.4 |
Test Group III |
100% |
917 |
5 |
1.3 |
Positive Control |
NA |
7696 |
5 |
11.0* |
NA – Not applicable; *-Positive Control used to confirm animal sensitization potential and validate procedures.
TABLE 1 – Body Weights and DPM Counts
Test Substance: H2925 (CAS No. 68130-53-0)
Skin Sensitization: Local Lymph Node Assay in Mice
Animal No. (in Group) |
Day of Study |
DPM Count |
|
Day 1 Wts. |
Day 6 Wts. |
||
Vehicle Control Group |
|||
1 |
23.5 |
24.3 |
967 |
2 |
24.2 |
25.0 |
1143 |
3 |
23.4 |
23.7 |
751 |
4 |
23.3 |
23.8 |
355 |
5 |
22.9 |
23.2 |
279 |
Test Group I – 25% concentration |
|||
1 |
26.3 |
27.3 |
811 |
2 |
24.8 |
24.9 |
664 |
3 |
21.5 |
22.6 |
1254 |
4 |
22.5 |
23.3 |
1461 |
5 |
25.4 |
25.9 |
1676 |
Test Group II – 50% concentration |
|||
1 |
25.2 |
25.6 |
1963 |
2 |
22.6 |
24.1 |
814 |
3 |
20.4 |
21.1 |
628 |
4 |
23.0 |
23.5 |
732 |
5 |
24.0 |
24.3 |
827 |
Test Group III – 100% concentration |
|||
1 |
24.1 |
24.4 |
836 |
2 |
23.2 |
24.0 |
615 |
3 |
24.9 |
25.1 |
525 |
4 |
22.1 |
23.4 |
673 |
5 |
24.5 |
25.2 |
1935 |
Positive Control Group |
|||
1 |
22.2 |
22.4 |
6743 |
2 |
22.7 |
23.4 |
1542 |
3 |
23.7 |
23.8 |
859 |
4 |
22.3 |
22.1 |
20841 |
5 |
23.8 |
23.9 |
8493 |
Note: Body weights are in grams.
TABLE 2 – Observations of Clinical Signs
Test Substance: H2925 (CAS No. 68130-53-0)
Skin Sensitization: Local Lymph Node Assay in Mice
Vehicle Control |
||||||
|
Day |
|||||
Reaction and Severity |
1 |
2 |
3 |
4 |
5 |
6 |
Appeared normal at each observation |
|
|
|
|
|
|
Test Group I – 25% concentration |
||||||
|
Day |
|||||
Reaction and Severity |
1 |
2 |
3 |
4 |
5 |
6 |
Appeared normal at each observation |
|
|
|
|
|
|
Test Group II – 50% concentration |
||||||
|
Day |
|||||
Reaction and Severity |
1 |
2 |
3 |
4 |
5 |
6 |
Appeared normal at each observation |
|
|
|
|
|
|
Test Group III – 100% concentration |
||||||
|
Day |
|||||
Reaction and Severity |
1 |
2 |
3 |
4 |
5 |
6 |
Appeared normal at each observation |
|
|
|
|
|
|
Positive Control |
||||||
|
Day |
|||||
Reaction and Severity |
1 |
2 |
3 |
4 |
5 |
6 |
Appeared normal at each observation |
|
|
|
|
|
|
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- H2925 (CAS No. 68130-53-0) produced a stimulation index < 3 in all groups of Test animals, and is not therefore considered a sensitizer (defined as producing a positive response).
- Executive summary:
A skin sensitization study was conducted on 3 groups of 5 female mice to determine if test substance H2925 (CAS No. 68130-53-0) possesses a significant potential to cause skin sensitization. Five females were assigned to each of three groups, designated Groups I -III. Test groups were treated with an appropriate dilution (25 or 50%) in 4: 1 acetone: olive oil, or 100% test substance. Each animal received 25 µltothe dorsum of each ear. Animals were treated once daily for three days. After a two-day rest period, all animals were injected with tritiated methyl-thymidine in the tail vein. Five hours later, animals were sacrificed, and the draining auricular lymph nodes removed and prepared for cell suspension and scintillation counting. A Vehicle Control group of five females was run concurrently, treated in the same manner with vehicle only instead of test substance or dilution. A Positive Control group of five females was also run concurrently, treated with alpha-hexylcinnamaldehyde as received.
The test substance produced a stimulation index < 3 in all groups of Test animals, and is not therefore considered a sensitizer (defined as producing a positive response).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Although ECHA is providing a lot of online material in your language, part of this page is only in English. More about ECHA’s multilingual practice.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
the-echa-website-uses-cookies
find-out-more-on how-we-use-cookies